IgG / Direct Mail Works Ltd / Mastercard / MEDLINE / St Edmundsbury Press Ltd / Adobe / /
Country
United Kingdom / Wales / /
Currency
GBP / / /
Facility
University of Sheffield / National Institute / University of Leicester / University of Southampton / University of Birmingham / / /
IndustryTerm
treatment of symptomatic Gaucher’s disease / particular chemical reaction proceeds / health technologies / energy / therapy for Gaucher’s disease / bank / dual-energy / Search results / /
National Knowledge Service / University of Leicester / School of Health and Related Research / Related Research / Department of Health Sciences / Clinical Excellence / National Screening Committee / University of Birmingham / National Institute for Health / National Institute for Health and Clinical Excellence / University of Sheffield / National Coordinating Centre for Health Technology Assessment / School of Health / Department of Health / NHS / University of Southampton / /
Person
Ken Stein Sally Bailey / John Powell / Aileen Clarke / Rob Riemsma / Sarah Llewellyn Lloyd / Chris Hyde / Tom Walley / Peter Davidson / / /
Position
Hb / Queen / National Clinical Director / Acrobat / Health EQ-5D EuroQol-5Dimensions NSCAG ERT enzyme replacement therapy National Specialist / Corresponding author / Cachexia General / Editor-in-Chief / Professor / Executive / Controller / /
Product
Cerezyme / /
PublishedMedium
Clinical Medicine / /
Technology
Health Technology / 137 Health Technology / tomography / transplantation / MRI / magnetic resonance imaging / health technologies / 1 West Midlands Health Technology / genotype / /
Health Technology Assessment 2006; Vol. 10: No. 24 Enzyme replacement therapy for Gaucher’s disease Feedback The HTA Programme and the authors would like to know your views about this report.